Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Central-line Exit-site Sealing With 2-octyl Cyanoacrylate Adhesive on CLABSI in Pediatric Cardiac Intensive Care Unit

NCT05721677 is registered in ClinicalTrials.gov with Rabin Medical Center as lead sponsor.

NCT NCT05721677
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05721677 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Central-line Exit-site Sealing With 2-octyl Cyanoacrylate Adhesive on CLABSI in Pediatric Cardiac Intensive Care Unit
Lead sponsor
Rabin Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
March 15, 2023
Completion date
September 15, 2026
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central-line associated blood stream infections (clabsi)